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Available online 8 March 2012Generating neural stem cells and neurons from reprogrammed human astrocytes is a potential
strategy for neurological repair. Here we show dedifferentiation of human cortical astrocytes
into the neural stem/progenitor phenotype to obtain progenitor and mature cells with a neural
fate. Ectopic expression of the reprogramming factors OCT4, SOX2, or NANOG into astrocytes in
specific cytokine/culture conditions activated the neural stem gene program and induced gener-
ation of cells expressing neural stem/precursor markers. Pure CD44+ mature astrocytes also
exhibited this lineage commitment change and did not require passing through a pluripotent
state. These astrocyte-derived neural stem cells gave rise to neurons, astrocytes, and oligodendro-
cytes and showed in vivo engraftment properties. ASCL1 expression further promoted neuronal
phenotype acquisition in vitro and in vivo. Methylation analysis showed that epigenetic modifica-
tions underlie this process. The restoration of multipotency from human astrocytes has potential
in cellular reprogramming of endogenous central nervous system cells in neurological disorders.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Keywords:
Astrocytes
Reprogramming
Neural stem cells
Induced pluripotent stem cellsIntroduction
Replacement of neurons after degeneration or damage is absent in
the vast majority of the mammalian central nervous system (CNS),
and neuronal loss is thought to be definitive in neurological diseases
such as stroke or Alzheimer's disease [1] . In apparent contrast, sev-
eral studies have demonstrated that some cells resembling glial cells
function as neural stem cells (NSCs) or progenitors in specific areas
of the adult brain, such as the ventricular subependymal zone andrological Sciences, Universi
: +39 0250320430.
. Comi).
C, induced Pluripotent Ste
C BY-NC-ND license.the subgranular zone of the hippocampus [1]. These data pose the
questions of [1] why glia in the vast majority of the CNS, such as
the cortical regions, apparently cannot produce new neurons and
[2] if these cells can be redirected towards neurogenesis when sup-
plied with the appropriate transcriptional factors and/or environ-
mental signals.
It has been demonstrated that astrocytes from murine cerebral
cortex can be directly differentiated into neurons by the forced ex-
pression of a single transcription factor, such as PAX6, Neurog2 orty of Milan, IRCCS Foundation Ca’ Granda Policlinico, Padiglione Ponti,
m Cell; NSC, Neural Stem Cell
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tion of endogenous astrocytes for neuronal repair of injured brain
tissue in neurological disorders. While such studies have evaluat-
ed astrocyte conversion in the murine context, a similar possibility
has yet to be demonstrated in human cells.
An essential element for developing such applications with ther-
apeutic value is a thorough comprehension of the mechanisms that
regulate reprogramming of adult cells into induced pluripotent stem
cells (iPSCs) [4] or directly into another committed lineage, such as
fibroblasts converted into neurons [5] and also specific neuronal
subpopulations like dopaminergic neurons [6]. Even if for the pur-
pose of autologous cell transplantation in neurological disorders, fi-
broblasts from patients resemble a much more suitable source of
neurons than astrocytes from patients, nevertheless, shading light
in the mechanisms that make possible to reprogram astrocytes
into NSCs is useful for the final goal of using these cells as endoge-
nous cell source for in situ neural repair in the CNS without any in-
vasive cell graft.
Reprogramming towards pluripotency involves the expres-
sion of master stem cell factors followed by a series of molecular
events that include generation of various intermediate cells and a
small fraction of bona fide pluripotent cells [4]. The developmen-
tal properties of these intermediate/partially reprogrammed cells
are still unclear. The four transcription factors Oct4, Sox2, Klf4,
and c-Myc (or substitution of the latter two with Nanog and
Lin28) can induce pluripotency in mouse and human fibroblasts
[7]. In fact, physiologically, OCT4, SOX2, and NANOG act in con-
cert to promote and maintain embryonic stem cell (ESC) identity
[4]. Human astrocytes can be reprogrammed into iPSCs, with sim-
ilar efficiencies to other cells, using the viral expression of four
reprogramming factors (Oct4, Sox2, Klf4, and c-Myc) [8]. Re-
markably, overexpression of a single factor like OCT4 in adult
cells can induce full reprogramming, as when it is expressed in
NSCs (human andmouse) [9,10], or promote the formation of an-
other phenotype, such as the generation of blood cells with its ex-
pression in human fibroblasts [11]. These data suggest that the
effect of these stem reprogramming factors changes in relation-
ship to the lineage and the differentiation stage of the cells
expressing them. These findings also have raised the possibility
that in conditions similar to those needed for reprogramming to
iPSCs, cells could acquire, as an alternative, a specific well-
defined lineage phenotype. Because of their full commitment,
these cells could be used for basic and therapeutic applications
with a greater safety relative to undifferentiated pluripotent
iPSCs, thus overcoming some limitations in the use of the latter.
In the current work, using the individual expression of OCT4,
SOX2, or NANOG, we demonstrated and characterized the direct
neural fate conversion of human astrocytes into multipotent neu-
ral progenitors, in vitro and in vivo. These cells were generated in
a manner that is independent of iPSC production.Material and methods
Cell cultures
Human cortical astrocytes (ScienCell) were cultured in astrocyte
medium (Science Cell) on poly-L-lysine-coated flasks. Lentiviral
vectors (pSIN) containing cDNA of OCT4, SOX2, NANOG, and Lin
28 [12] were obtained from Addgene. Astrocyte transductionswere performed at 24 h post-plating on coated dishes as described
[12] or with nucleofection [13]. Transfected cells were cultured in
ESC/iPSC media (mTERS, Stem Cells) or in human NSC medium
(Stem Cell Inc.) supplemented with EGF and FGF and heparin,
according to the manufacturers’ instructions. Colonies with human
NSC morphology (NSC colonies) were generally picked for expan-
sion on day 21 post-transduction. Control iPSCswere derived as pre-
viously described from human fibroblasts with OCT4, SOX2, NANOG,
and LIN28 vectors [12]. To select the CD44+population, primary as-
trocytes were incubated with PE-labeled anti-CD44+antibody (BD
Pharmingen) followed by FACS selection (FACS Vantage BD). An ap-
propriate isotype Ig control was used. ASCL1 vector (OriGene) was
transfected as described above for the other vectors in AstroNSC
cells.
Functional/phenotypic analysis
For expansion and differentiation of NSC clones, the cells were
cultured in NSC expansion and differentiation medium (Stem
Cell Inc.) according to the manufacturer's instructions. Cells
were fixed in 4% paraformaldehyde (PFA) for 10 min. Then they
were permeabilized with 0.5% Tween-20 in PBS and then ex-
posed to 0.1% Tween-20 with 10% horse serum. We incubated
the cells with primary antibodies overnight and with secondary
antibodies for 1 h when unconjugated primary antibodies were
employed (Alexa Fluor, Invitrogen). We used the following pri-
mary antibodies: SSEA-3 (1:100, R&D), SSEA-4 (1:500, DSHB),
TRA1-60 (1:500, Chemicon), TRA1-81 (1:500, Chemicon), Pax6
(1:200, Millipore), nestin (1:200, Millipore), Sox2 (Millipore
1:200), TuJ1 (1: 200, Millipore), GFAP (1:300, SIGMA), anti-mi-
crotubule-associated protein 2 (MAP2; 1:100, mouse, Sigma-
Aldrich), NF (1: 200, SIGMA), synapsin (1:500, Abcam), and
GABA (1:200, Abcam). For all images, we used a confocal LEICA
LCS2 microscope. Cell counts and measurements were quantified
as described previously [14,15] and analyzed using NIH Image
Software, and statistical calculations were performed using
StatsDirect software. Teratoma formation was investigated by in-
jection into immunocompromised mice as described [13]. Tis-
sues and teratomas were evaluated for the presence of the
three germinal layers (mesoderm, endoderm, and ectoderm)
through histological examination with hematoxylin and eosin.
Microarray analysis of gene expression: Astro vs AstroNANOG
Microarray expression analysis of AstroNANOG and parental as-
trocytes was performed with human genome GeneChip Gene
1.0 ST Array (Affymetrix, Santa Clara, CA). This analysis was per-
formed by Imagenes Laboratory (Germany). The GeneChip IVT
Express Kit and the GeneChip Hybridization wash and stain kit
were used with 100 ng of total RNA that was mixed with 2 μl
of 1/500,000 diluted spikes. Synthesis of the first strand and
the second strand of cDNA was performed according to the kit
instructions at 42 °C, transcribed, and amplified into cRNA. The
cRNA was quantified by NanoDrop. Then fragmentation of
12.5 μg cRNA was performed and hybridized onto the GeneChip
according to the Affymetrix protocol. An Affymetrix RUO plat-
form was used and data processed using the Affymetrix GCOS
program. Quality control was performed based on Affymetrix
quality-control metrics. All chips were normalized by the quan-
tile method and background corrected using robust multi-array
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summarized using median polish to obtain the probe set level
measurement. Hierarchical cluster analyses were performed
with 1-PCC (Pearson correlation coefficient) as the distance pa-
rameter. The maximum distance between cluster members was
used as the basis to merge lower-level clusters (complete link-
age) into higher-level clusters. To assess the certainty of the
existence of a cluster, we applied multiscale bootstrap resam-
pling (10,000 bootstraps) to the hierarchical clustering of the
six samples and calculated P values of the hypotheses as well
as bootstrap probabilities for each cluster. Microarray data are
available in the GEO database.
Cell transplantation
As donor cells for in vivo experiments, we used AstroNSCs and
CD44-NSCs±ASCL1 that were genetically modified to express
the GFP gene reporter. Cells were transplanted into the lateral
ventricles of anesthetized 1-to-2-day-old mice pups as described
previously [16]; 2 μl of cell suspension (100,000 viable cells/μl)
was slowly injected. As control, mice received human fibroblasts
or freeze-killed cells. The immunosuppressor FK506 adminis-
tered i.p. at 1.0 mg/kg body weight was administered to all ani-
mal groups for the entire length of the experiment. At least 12
animals for each experimental group were analyzed. All animal
experiments were performed according to institutional guide-
lines in compliance with national and international law and
policies.
Tissue analysis
Two months after transplantation, the animals were killed, per-
fused, and fixed with 4% PFA in PBS (pH 7.4). The brain was iso-
lated, immersed in PFA solution for 1 h, and then in sucrose 20%
solution in PBS (pH 7.4) overnight and frozen. The tissues were
cryosectioned and mounted on gelatinized glass slides. Cerebral
tissue was cut in the coronal plane from the frontal lobes (10 or
50 μm for stereological cell count). All CNS sections were blocked
with 1% fetal calf serum in PBS and permeabilized with 0.25% Tri-
ton X-100. Sections were processed for multiple markers to de-
termine the cellular phenotype of GFP-human donor cells.
Immunohistochemistry was performed as described previously
[14–16] for the following proteins: nestin, TuJ1 (1:200; Chemi-
con), NeuN (1:200; Chemicon), MAP2 (1:200; Sigma), neuronal
nuclei (NeuN), NF (1: 200, SIGMA), GAD67 (1:500, DSHB),Fig. 1 – OCT4/SOX2/NANOG-transduced human cortical astrocytes g
illustration of NSC generation from human cortical astrocytes (Ast
NANOG. The cells were cultured in ESC/iPSC or NSC media. NSC colon
c) Bright-field images of human untransduced astrocytes (Astro) a
(AstroNANOG) transduced astrocyte colonies (dashed lines indicate
condition). Scale bar b: 150 μm; scale bar c, Astro and AstroOCT4: 1
Quantification of colonies in human astrocytes after transduction
bar) at 21 days (12 biological replicates; error bars, s.d.; *P<.00001)
nestin in AstroNANOG colonies. Similar results were obtained with
Quantification of NSC marker expression as a percentage of positiv
Global gene analysis of NSC marker expression of Astro vs AstroNAoligodendrocyte marker O4 (1:200; Chemicon), and GFAP
(mouse monoclonal, 1:200; Sigma). Mouse and rabbit antibodies
conjugated with RPE, CY3, or biotin (1:200; Jackson ImmunoRe-
search and Dako) were employed for 1 h at room temperature
as secondary antibodies when unconjugated primary antibodies
were used. Co-expression of GFP/YFP and tissue-specific markers
was evaluated using a conventional fluorescence microscope
(Zeiss Axiophot) and laser confocal scanning (Leica TCS SP2
AOBS) microscopic analysis. A stereological count of total GFP-
positive cells and double-labeled cells with neural and glial
markers was conducted using a modified version of the optical
fractionator method on every fifth section in selected areas
with three ROIs (0.3×0.3 mm). Resulting numbers were tallied
and multiplied by tissue thickness (50 μm) and the number of in-
tervening sections (n=5) as described previously [16]. Repeated
measures ANOVA were used for statistical analyses.
Sample labeling and hybridization to NimbleGen array for meth-
ylation analysis
The labeling of dsDNA, microarray hybridization, and scanning
were performed by the Imagenes Laboratory according to the
manufacturer's standard protocol. The NimbleGen 3x720K CpG Is-
land Plus RefSeq Promoter Arrays were used. Each array covers
important regulatory elements including RefSeq gene promoters
and 27,728 annotated CpG islands with 100 bp probe spacing
throughout all tiled regions. Tiling of each RefSeq gene promoter
(~22,532 total) begins 2.4 kb upstream of the transcription start
site and extends downstream 0.6 kb for a total of 3 kb of promoter
coverage per gene. This array also tiles through various positive,
negative, and non-CpG control regions to facilitate assessment of
experimental performance. Data were extracted from scanned im-
ages by using NimbleScan extraction software. Microarray data
are available in the GEO database.
DNA methylation ﬁnd-peaks analysis
DNA Methylation Find-Peaks analysis identifies regions of signifi-
cant positive enrichment in IP-based methylation microarray
data, using a modified ACME algorithm for peak identification
[17]. The analysis accepts normalized, scaled log2-ratio data in
GFF format. Map-Peaks Analysis associates peaks with genomic
features, such as transcription start sites or CpG islands. Per peak
position, the peak scores of the Astro and AstroNANOG experi-
ments were subject to a t-test evaluation, which resulted in a Pive rise to neural stem cell (NSC) colonies.a) Schematic
ro). Human astrocytes were transfected with OCT4, SOX2, or
ies were observed between days 14 and 21 post-transfection. b,
nd OCT4- (AstroOCT4), SOX2- (AstroSOX2), or NANOG-
the spheres) in ESC/iPSC medium or NSC medium (n=12/
50 μm; AstroSOX2: 75 μm; AstroNANOG: 100 μm. d)
in ESC/iPSC medium (gray bar) or in neuronal medium (pink
. e) Immunocytochemical expression of SOX2, PAX6, CD133, and
AstroOCT4 and AstroSOX2 colonies. Scale bar: 150 μm. f)
e cells in AstroOCT4, AstroSOX2, and AstroNANOG colonies. g)
NOG cells.
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group peak scores (=fold change) was calculated by the ratio of
the respective group median peak scores.Results
Reprogramming of human cortical astrocytes by the ectopic
expression of individual stem transcription factors
We investigated the effects of the individual expression of the key
reprogramming factors OCT4, SOX2, and NANOG in human corti-
cal astrocytes. Transduced versus untransduced astrocytes were
examined between 14 and 21 days post-transduction (D14–
D21) in human ESC/iPSC culture conditions. Fig. 1a summarizes
the experimental design. The starting population was positive
for astrocytic markers like CD44 and GFAP and completely nega-
tive for neural stem cells markers like CD133, CD15, SOX2 and
PAX6. No neural stem cells clones both as adherent cell clusters
or neurospheres were detected both in bulk and clonal condition
in neural stem cells medium.
Unlike untransduced astrocytes, astrocytes transduced with
OCT4 (AstroOCT4), SOX2 (AstroSOX2), or NANOG (AstroNANOG)
gave rise to colonies of small cells resembling NSCs (Fig. 1b). The
vast majority of these cells were adherent colonies composed of
small round/spindle cells, while the other cell populations took
the structure of spheroids similar to neurospheres.
To enhance the emergence of NSCs, we used human NSC
culture conditions that included neuronal medium supplemented
with EGF and FGF (Fig. 1c). This treatment increased the frequen-
cy of NSC colony emergence from astrocytes by 2- to 3-fold,
compared with untreated astrocytes, while no effect was
detected from control untransfected astrocytes (Fig. 1d). The
number of colonies obtained was significantly greater with
NANOG than with SOX2 or OCT4 (P<.00001) (Fig. 1d). NSCs
were then clonally selected and further expanded in the neuronal
medium. Supplementary Video 1 shows the typical contrast-
phase aspect of these cells. These neural stem colonies were pos-
itive for neuronal precursor-specific proteins like SOX2, PAX6,
CD133, and nestin (Fig. 1e), and they were negative for astrocytic
markers like CD44 and for pluripotency factors such as SSEA-3
and Tra-1–60. We evaluated the self-renewal AstroNSCs in vitro
by growing them at clonal density. Clones can be passaged and
generate secondary and tertiary NSCs clones. These data indicate
that single reprogramming factors are sufficient to initiate the
emergence of NSCs from astrocytes and that these cells are re-
sponsive to stimulation by NSC growth factors.
To further characterize these cells molecularly, we performed
genome-wide expression profiling of AstroNANOG-derived NSCsFig. 2 – Conversion of astrocytes into NSCs by OCT4/SOX2 and NANO
NANOG-NSCs presented a different morphological aspect under con
obtained from fibroblasts by contemporaneous transfection of OCT
pluripotency markers SSEA3 and TRA-1-60. Scale bar: 150 μm. b) Qu
and human fibroblasts transduced with OCT4, SOX2, NANOG, and L
gene profile in parental astrocytes and in AstroNANOG. d) Teratom
injected with astrocytes, AstroNANOG, and saline (CTR). Scale bar:in comparison with parental astrocytes. AstroNANOG cells showed
increased expression of NSC/precursor markers with a parallel re-
duction in astrocyte-specific gene expression, resulting in a shift
towards the NSC identity (Supplementary Table 1). Overall, the
gene expression pattern of AstroNANOG cells was significantly dif-
ferent relative to untransfected astrocytes as demonstrated by hi-
erarchical clustering of signals, the heat map, and the volcano-
plot t-test (Supplementary Fig. 1). To confirm that cortical astro-
cytes were converted and that our results were not linked to the
presence of other cells such as NSC/precursors, we selected a pop-
ulation of CD44+ astrocytes by FACS (Supplementary Fig. 2).
CD44+ cells mark a population of fully committed astrocytes
that do not differentiate into neuronal or oligodendrocytic lineages
[18]. After sorting the purified cells are all positive for CD44+ as
shown in Supplementary Fig. 2c and are negative for neural stem
cells markers like CD133, CD15, SOX2 and PAX6 (data not
shown). We then transduced the purified CD44+ cells using
reprogramming factors (Supplementary Fig. 2). We demonstrated
that these cells also generated NSCs with a similar efficiency ob-
served with the whole primary culture. The untrasfected CD44+
never generated clones resembling NSCs. The isolated CD44-NSCs
clones were negative for CD44 and positive for SOX2, PAX6,
CD133, and nestin (Supplementary Fig. 2). These cells are expand-
ed in vitro in NSC medium and were grown at clonal density. They
generated secondary and tertiary NSC clones demonstrating that
they are self-renewing cells. Thus, fully committed human cortical
astrocytes can be reprogrammed into NSCs.
Direct reprogramming into NSCs does not require passage through
a pluripotent state
Expression of OCT4 alone has been demonstrated as sufficient to
reprogram NSCs into iPSCs [11]. We wanted to investigate wheth-
er the individual expression of OCT4/SOX2/NANOG could
reprogram astrocytes into iPSCs or if the generation of NSCs was
obtained through passage into a pluripotent state. We observed
no formation of typical iPSCs in culture, and the pluripotencymarkers
SSEA3, SSEA4, TRA-1–60, and TRA-1–81 were not detectable in the
transduced condition, whereas both features increased during
establishment of iPSCs from human fibroblasts transduced
contemporaneously with four factors (OCT4/SOX2/NANOG/Lin28)
as previously described [12] (Fig. 2 and Supplementary Fig. 3).
We analyzed the expression in AstroNANOG cells of a specific
gene subset known to be crucial for induction and maintenance
of pluripotency in NSCs derived from astrocytes. Apart from the
up-regulation of NANOG itself, NANOG expression did not modify
the pluripotency gene expression pattern as evaluated by microar-
ray analysis (Fig. 2). In contrast to the fully reprogrammed iPSCs,
transplantation of AstroNANOG-transduced or untransducedG does not require the pluripotent state.a) A colony of CD44+
trast-phase microscopic observation relative to the iPSC colony
4/SOX2/NANOG/LIN28. iPSCs were positive for
antitative analysis of SSEA3 and Tra-1-60 in Astro, AstroNANOG,
IN28, over the human iPSC derivation timeline. c) Pluripotency
as derived from human iPSCs and testicular sections from mice
300 μm.
1534 E X P E R I M E N T A L C E L L R E S E A R C H 3 1 8 ( 2 0 1 2 ) 1 5 2 8 – 1 5 4 1astrocytes into immunodeficient mice did not generate teratomas
composed of all three germ layers or any overgrowth resembling a
tumor (Fig. 2). Overall, our results indicated that the Astro-derivedNSCs were directly diverted towards an NSC fate without passing
through a detectable phenotype or functional status of pluripotent
cells.
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Global gene expression analysis showed that the AstroNANOG-
derived cells exhibited a gene expression pattern consistent with
that of neuronal stem/precursor cells, supporting the hypothesis
that they may have functional neurogenic properties of multiple
neuroectodermal phenotypes. To functionally characterize neuro-
nal differentiation capacity, AstroNSC clones (for each condition:
OCT4, SOX2, NANOG) were cultured in human neuronal differen-
tiation medium. The resulting progeny presented features consis-
tent with differentiation into the three neuroectodermal lineages
(Fig. 3). After 15 days of differentiation, we observed 41.4±4.9%
neurons (positive for neuronal markers TuJ1, MAP2, and NF;
quantification performed with MAP2), 33.6±4.2% astrocytes
(positive for GFAP), and 7.9±1.3% oligodendrocytes (positive for
O4 in AstroNANOG-NSCs). The remaining cells had features of
neuronal precursors positive for SOX2. Similar results were
obtained with AstroNSCs transfected with OCT4 or SOX2 and also
with CD44+-reprogrammed cells (Supplementary Fig. 4). The
AstroNSC-derived neurons presented typical neuronal morphology
and not only were positive for pan-neuronal markers but also for
synapsin, supporting the presence of synaptic contact, and for the
neurotransmitter GABA, both suggesting a functionally correct com-
petence of these cells (Supplementary Fig. 4).
Overexpression of the helix–loop–helix ASCL1 can induce neuro-
genesis inNSCs [19] and rodent astrocytes [2] and, in associationwith
other factors, inmurine and human fibroblasts [5,20]. Thus, we trans-
duced AstroNSCs with ASCL1 (Fig. 4, Supplementary Fig. 5). Trans-
fected cells had a significantly augmented number of neurons
compared with untreated cells (transfected cells 47.4 vs 36.3%,
P<.00001). The ASCL1 neurons presented highly complex morphol-
ogies and expressed the pan-neuronal markers TuJ1, MAP2, and NF.
Indeed, they were positive for synapsin and also for neurotransmit-
ters like GAD67 positivity, the enzyme for the biosynthesis of the
neurotransmitter GABA suggests (Fig. 4, Supplementary Fig. 5).
Neuronal differentiation of NSCs from astrocytes in vivo
To assess the ability of AstroNSC clones cells to engraft and
differentiate into neurons in vivo in mammalian CNS, Astro/
CD44NANOG cells were transplanted intracerebroventricularly in
immunosuppressed mice (n=12) to characterize its in vivo
potential (Fig. 5a). Animals transplanted with fibroblasts and
freeze-killed cells were used as control. Human donor cells ulti-
mately engrafted in the brains of all transplanted animals. In par-
ticular, donor-transplanted cells incorporated into the gray and
white matter of the brain, migrating from the cerebral ventriclesFig. 3 – In vitro generation of three neuroectodermal lineages in par
AstroNSC differentiation into neurons, astrocytes, and oligodendrocy
medium. The cell phenotype was determined after 15 days of differe
positive for TuJ1 (b) andMAP2 (c), astrocytes positive for GFAP (d), an
differentiation efficiency into neurons (MAP2), astrocytes (GFAP), an
AstroOCT4/SOX2/NANOG had similar neuronal differentiation abiliti
l–m) The AstroNSC-derived neurons acquired a complex mature phe
double staining with MAP2, green) and neurotransmitters like GAD6
GABA suggests. Scale bar: b, c, i, j, k: 150 μm; d, e: 50 μm; l, m: 50 μmwithin 2 months after delivery. These cells were observed also in
cortical areas.
The total number of GFP-positive human donor AstroNSCs in
the brain sections from treated animals was determined by stereo-
logical estimation at 2 months post-transplantation. The results
indicate that cell number was 131,764±19,546 cells (65.88±
14.38% of the initial population of 200,000 cells) in the case of
AstroNANOG cells, and 136,872±16,845 cells (68.44±12.31% of
the initial population of 200,000 cells). Donor-derived cells exhib-
ited a predominantly neuronal phenotype (MAP2: 39.3±5.2%
AstroNANOG; 37.2±4.8% CD44NANOG). These cells presented
highly mature, morphologically differentiated cells with complex
and long neuritic extensions. A proportion of the engrafted cells
retained NSC features, while the remaining cells acquired a glial
phenotype (GFAP: 35.4±4.9% AstroNANOG, 36.3±3.8% CD44NA-
NOG; O4: 6.1±1.6% AstroNANOG, 6.6±1.9% CD44NANOG)
(Fig. 5). Donor-derived neuronal cells express also neurotransmit-
ter proteins like GABA (Supplementary Fig. 6).
The ability to generate neuronal progenitors and the presence
of the three neuroectodermal lineages supports the in vivo func-
tional capacity of Astro-derived cells.
The transplantation of AstroNANOG/ASCL1+ cells gave rise to a
similar number of engrafted cells and a larger proportion of a neuro-
nal phenotype, confirming the pro-neurogenic effect of ASCL1 ex-
pression (Fig. 5).
Taken together, our data demonstrate that AstroNSCs can give
rise to functional neuronal progenitor-like cells that can differen-
tiate into neuronal lineages in vitro and in vivo.
Epigenetic modiﬁcations underlie the reprogramming of astrocytes
into NSCs
Astro-derived NSCs are likely derived by epigenetic reprogram-
ming, and we analyzed their DNA methylation patterns
relative to untransfected astrocytes. We compared three human
AstroNANOG-NSC clones to the astrocytes from which they were
derived using NimbleGen 3x720K CpG Island Plus RefSeq Promot-
er Arrays. This approach allowed the interrogation of promoter re-
gions and CpG sites. DNA Methylation Find-Peaks analysis
identified regions of significant positive enrichment in microarray
data, using a modified algorithm for capturing microarray enrich-
ment (ACME) for peak identification [17] (Fig. 6a). Per peak posi-
tion, the peak scores of the AstroNANOG and astrocyte
experiments were subject to a t-test evaluation. A total of 6667
of 67,652 regions analyzed were found to significantly differ
(Supplementary file 1). We termed the differentially methylated
regions R-DMRs. The number of R-DMRs that wereticular in neurons from AstroOCT4/SOX2 or NANOG.Protocol of
tes. AstroNSCs were cultured in human neuronal differentiation
ntiation. b–e) Differentiation of AstroNANOG cells into neurons
d oligodendrocytes positive for O4 (e). f–h) Quantification of the
d O4 for the three conditions (NANOG, OCT4, SOX2). i–k)
es as demonstrated here with immunocytochemistry for MAP2.
notype and were positive for synapsin (l, shown here in red as
7 positivity, enzyme for the biosynthesis of the neurotransmitter
.
1536 E X P E R I M E N T A L C E L L R E S E A R C H 3 1 8 ( 2 0 1 2 ) 1 5 2 8 – 1 5 4 1
1537E X P E R I M E N T A L C E L L R E S E A R C H 3 1 8 ( 2 0 1 2 ) 1 5 2 8 – 1 5 4 1hypermethylated in astrocytes significantly predominated over
hypomethylated, as shown in Fig. 6b.
We then performed a gene ontology annotation analysis of the
genes near these regions (within 1000 bp of the transcriptional
start site (TSS) of a gene) that revealed significant enrichment
for genes involved in developmental and regulatory processes
(Figs. 6c, d). For example, 22% of the genes that were hypermethy-
lated in astrocytes compared to AstroNSCs and 38% of the genes
that were hypomethylated in astrocytes compared to AstroNA-
NOG were involved in developmental processes.
When we observed the overlap of the R-DMRs with known
binding sites for OCT4, SOX2, and NANOG [21], we saw that
some of the R-DMRs belong to these regions (Supplementary
File 3). We then correlated the global gene expression profile of
astrocytes and AstroNANOG and the known OCT4, SOX2, and oc-
cupancy. NSC genes that were up-regulated in AstroNANOG cells
were significantly related with predicted OCT4, SOX2, and
NANOG binding sites (Figs. 6e–j). These observations indicated
that the sites of epigenetic and gene expression changes during
reprogramming of astrocytes to NSCs are tightly linked to genes
that are functionally important for pluripotency.Discussion
Our present study demonstrates for the first time that expression
of a single key stem transcription factor is sufficient to rapidly and
efficiently convert human cortical astrocytes into neural stem/pre-
cursor cells. OCT4/SOX2/NANOG genes were selected because of
their demonstrated roles in the maintenance of pluripotency and
reprogramming [4]. Astro-derived NSCs are self-renewing and mul-
tipotent, present specific NSCs morphology and marker expression,
and respond to NSC growth factor stimuli. To unequivocally demon-
strate that terminally differentiated astrocytes can be directly con-
verted into NSCs using this strategy, we also employed CD44+-
selected fully mature astrocytes, ruling out the possibility that the
presence of rare stem/precursor cells can account for our observa-
tions. Furthermore, no spontaneous conversion into NSCs or neurons
in control untransfected or mock transfected astrocytes was ob-
served in our culture conditions.
The change in lineage fate occurredwithout the need for passage
through a pluripotent state similar to the iPSCs. This direct conver-
sion approach may allow avoidance of some complications linked
to the undifferentiated state of iPSCs, including the risk of teratoma
formation. In the context of the production of cells for clinical appli-
cation for regenerative medicine in neurological diseases, further
studies are warranted to investigate if, with a similar strategy, it isFig. 4 – ASCL1 promotes neuronal differentiation of Astro and CD4
NANOG-ASCL1 differentiation into neurons. Astro/CD44+NSCs wer
phenotype was analyzed after 15 days. b) AstroNANOG-ASCL neuro
positive for pan-neuronal markers MAP2 (green) and TuJ1 (red), sh
AstroNANOG-ASCL and CD44-NANOG-ASCL1 were present at higher r
to AstroNANOG. The neurons are shown here with immunocytoche
efficiency into neurons (MAP2), demonstrating that efficiency was s
ASCL1 vs AstroCD44-NANOG. g, h) The AstroNSC-derived neurons w
with MAP2, green (g) or in single staining (h)).Scale bar: b: 50 μm;possible to directly convert into NSCs other cells that are of a more
distant embryonic lineage, like human skin fibroblasts.
The functional differentiation ability of Astro-derived NSCs in
neurons and glia in vitro and in vivo confirmed the acquisition of
NSC fate by human astrocytes. A remarkable tendency of these cells
to differentiate into neurons was observed. These cells are positive
not only for pan-neuronal antigens but also for synaptic proteins
and neurotransmitters, supporting their functionally correct features.
By inserting the transcription factor ASCL1,we furthermodulated
and promoted the neuronal differentiation ability of reprogrammed
cells. ASCL1, also known asMash1, belongs to the bHLH transcription
factors of the achaete-scute family and is a telencephalic transcription
factor upstream of Dlx2 during neuronal specification in develop-
ment [22,23]. This factor, in combination with other neurogenic
genes, has been described to promote the neuronal phenotype in
murine and human fibroblasts [5,20] and murine astrocytes [3,4].
Also in our experiments, the expression of ASCL1 was neurogenic
and associated with the generation of a larger number of neurons
with a more complex and mature phenotype. Overall, our data sug-
gest that astrocytes can be induced to acquire a specific desired phe-
notype also following multiple sequential genetic modifications.
Other combinations of multiple neurogenic transcription factors
might produce a wider spectrum of neuronal phenotypes.
Remarkably the acquisition of a neuronal phenotype was also
obtained in vivo after grafting into the rodent brain. This finding
is promising ground for future attempts to convert endogenous
astrocytes directly in vivo with transcription factor expression.
To investigate the molecular mechanisms underlying this
astrocyte-to-NSC conversion, we performed genome-wide expres-
sion and methylation analysis. The results demonstrated that the
presence of key stem factors activates specific features of the
NSC-fate transcription program. It is likely that auto-regulation
and positive feedback loops involving reprogramming factors as
well as feed-forward regulation of common target genes [24]
maintain the expression of key neural stem-determining genes
and stabilize the phenotype.
In complementary findings, we showed that the same genes un-
dergo extensive epigeneticmodifications. Significantmodification of
the transcriptional profile could also lead to genome-wide changes
in epigenetic features such as DNA methylation and chromatin
remodeling that further promote the stability of the new transcrip-
tional network. The analysis of differentially methylated regions
revealed a significantly higher methylation with regard to NSCs. In-
tegrating these data with known mapped biding sites of OCT4/
SOX2/NANOG [25], we conclude that the reprogramming is likely
associated with the direct binding of reprogramming factors to the
regulatory loci of neuronal-specific genes.4+NANOG cells.a) Schematic illustration of Astro and CD44+
e cultured in human neuronal differentiation medium. The cell
ns presented long dendritic arborization and axons and were
own here as merged signal. c–e) Neurons differentiated from
ates and with a complexmaturemorphology in culture relative
mistry for MAP2. f) Quantification of the differentiation
ignificantly higher with AstroNANOG-ASCL1 and CD44-NANOG-
ere positive for GAD67 (shown here in red as double staining
c, d: 150 μm; g: 50 μm; h: 70 μm.
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tial reprogramming as a possible strategy for autologous cell ther-
apy not only ex vivo but also prospectively in vivo by direct
conversion of endogenous astrocytes in the CNS for the treatment
of neurological diseases.Funding
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